Hillstream Biopharma Financials

HILSDelisted Stock  USD 0.39  0.01  2.50%   
Based on the key measurements obtained from Hillstream Biopharma's financial statements, Hillstream Biopharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.
  
Understanding current and past Hillstream Biopharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hillstream Biopharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Hillstream Biopharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Hillstream Biopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hillstream Biopharma. Check Hillstream Biopharma's Beneish M Score to see the likelihood of Hillstream Biopharma's management manipulating its earnings.

Hillstream Biopharma Stock Summary

Hillstream Biopharma competes with Virax Biolabs, Revelation Biosciences, Kiora Pharmaceuticals, ZyVersa Therapeutics, and Palisade Bio. Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death for the treatment resistant cancers. The company was incorporated in 2017 and is based in Bridgewater, New Jersey. Hillstream Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.
Foreign Associate
  UK
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS4327051011
Business Address1200 Route 22
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.hillstreambio.com
Phone908 955 3140
CurrencyUSD - US Dollar

Hillstream Biopharma Key Financial Ratios

Hillstream Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hillstream Biopharma's current stock value. Our valuation model uses many indicators to compare Hillstream Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hillstream Biopharma competition to find correlations between indicators driving Hillstream Biopharma's intrinsic value. More Info.
Hillstream Biopharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Hillstream Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Hillstream Biopharma Market Pulse

 Quote0.39
 Change(%)  2.50 
 Change0.01 
 Open0.4
 Low0.37
 High0.41
 Volume0
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Hillstream Biopharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Hillstream has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Hillstream Biopharma's financials are consistent with your investment objective using the following steps:
  • Review Hillstream Biopharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Hillstream Biopharma's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Hillstream Biopharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Hillstream Biopharma's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Hillstream Biopharma November 25, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Hillstream Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hillstream Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hillstream Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Hillstream Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hillstream Biopharma's daily price indicators and compare them against related drivers.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Hillstream Stock

If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk